YBL-006

· Y Biologics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YBL-006, covering 2022-12-05 to 2022-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation/Dose Expansion Study of YBL-006 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]